Baird Starts Reneo Pharmaceuticals (RPHM) at Outperform

January 26, 2022 4:20 PM EST
Get Alerts RPHM Hot Sheet
Price: $2.08 -1.89%

Rating Summary:
    6 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 19 | New: 11
Trade Now! 
Join SI Premium – FREE

Baird analyst Brian Skorney initiates coverage on Reneo Pharmaceuticals (NASDAQ: RPHM) with a Outperform rating and a price target of $28.00.


For an analyst ratings summary and ratings history on Reneo Pharmaceuticals click here. For more ratings news on Reneo Pharmaceuticals click here.


Shares of Reneo Pharmaceuticals closed at $7.23 yesterday.


You May Also Be Interested In





Related Categories

Hot New Coverage, New Coverage